These differences were statistically significant compared to the diabetes + saline group (p < 0.05), indicating a potential anti-inflammatory effect of Rilmenidine treatment on TNF-α levels in the sciatic nerve (Table 3). This evidence concerns the gene TNF and diabetes mellitus.